Skip to content
vaccines hero image
vaccines hero image

Vaccines

Vaccines contain antigenic substances capable of inducing immunity against an infective agent or toxin.

They are frequently administered prophylactically but are increasingly being researched and developed in a therapeutic context (eg cancer vaccines which are designed to equip a patient’s immune system to treat an existing cancer).

While the global market for vaccines is less than 3% of the total pharmaceuticals market, World Health Organization research suggests that over the next few years, the vaccine market will enjoy a growth rate of 10% to 15% per year versus the 5% to 7% seen in the overall market.

To take a share of this expanding market, companies must navigate a number of challenges. The assessment, licensing and control of vaccines (which are biological medicinal products) occurs in an environment of rapid innovation and complex quality concerns. Our deep experience of vaccines, combined with the fact that our team includes lawyers with degrees in relevant scientific areas (molecular biology, biochemistry, genetics etc), enables us to quickly grasp evolving issues and technical concepts and provide nuanced and tailored advice.

We are trusted by many of the world’s leading vaccine companies to help them navigate all stages of the vaccine lifecycle. Our clients include Merck, GlaxoSmithKline, Johnson & Johnson, Pfizer and Novartis.

News & insights

Microscope with lights on

Blog Post: 14 JUNE 2021

Process patents – paper tigers or effective protective rights?

Thoughts on “sufficient likelihood” in the sense of section 140c German Patent Act (PatG).

Read more
A droplet of liquid failing into pharmaceutical test tubes

Publications: 09 JUNE 2021

A&O hosts webinar on drug formulations in life sciences transactions

On Tuesday 25 May 2021, Allen & Overy IP associate Tine Carmeliet chaired a presentation with IP partner Keren Livneh and IP associate Megan McMellon and M&A associate Zara Sproul on “Drug…

Read more
Skyline

Publications: 27 MAY 2021

Hitachi Metals: Essential Patents Recognised as Essential Facility in China

On 23 April 2021, the Ningbo Intermediate Court handed down the long-awaited decision in Ningbo Ketian Magnet Co., Ltd. v. Hitachi Metals, Ltd. 

Read more
Vials of medication during production

Publications: 15 DECEMBER 2020

Healthcare accent is on smaller deals

Transactions in the U.S. healthcare space rebounded in autumn, although with a greater proportion of smaller deals than in recent years. 

Read more

Download our sector brochure

Life sciences A&O red molecules

An insight in to our Life Science and Healthcare sector 2021

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.